Results 31 to 40 of about 1,219,846 (287)

Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2 [PDF]

open access: yesViruses
The continuous emergence of SARS-CoV-2 variants caused the persistence of the COVID-19 epidemic and challenged the effectiveness of the existing vaccines. The viral proteases are the most attractive targets for developing antiviral drugs.
Davide Gentile   +9 more
doaj   +3 more sources

In Silico and In Vitro Studies of the Approved Antibiotic Ceftaroline Fosamil and Its Metabolites as Inhibitors of SARS-CoV-2 Replication [PDF]

open access: yesViruses
The SARS-CoV-2 proteases Mpro and PLpro are critical targets for antiviral drug development for the treatment of COVID-19. The 1,2,4-thiadiazole functional group is an inhibitor of cysteine proteases, such as papain and cathepsins.
Cássia Delgado   +11 more
doaj   +2 more sources

Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors [PDF]

open access: yesViruses, 2019
Proteases are a major enzyme group playing important roles in a wide variety of biological processes in life forms ranging from viruses to mammalians. The aberrant activity of proteases can lead to various diseases; consequently, host proteases have been
Kyeong-Ok Chang   +4 more
doaj   +3 more sources

Computer-Aided Prediction of the Interactions of Viral Proteases with Antiviral Drugs: Antiviral Potential of Broad-Spectrum Drugs. [PDF]

open access: yesMolecules, 2023
Human society is facing the threat of various viruses. Proteases are promising targets for the treatment of viral infections. In this study, we collected and profiled 170 protease sequences from 125 viruses that infect humans.
Ren P, Li S, Wang S, Zhang X, Bai F.
europepmc   +2 more sources

Serine protease-driven entry and S2 ' cleavage flexibility of feline coronavirus during feline enterocyte infections. [PDF]

open access: yesPLoS Pathogens
Coronaviruses not only hijack host cells to serve as viral factories but also exploit host proteolytic systems to activate their spike (S) protein, the key glycoprotein mediating receptor binding and membrane fusion.
Bixia Chen   +5 more
doaj   +2 more sources

Viral proteases: Structure, mechanism and inhibition [PDF]

open access: yes, 2022
Viral proteases are diverse in structure, oligomeric state, catalytic mechanism, and substrate specificity. This chapter focuses on proteases from viruses that are relevant to human health: human immunodeficiency virus subtype 1 (HIV-1), hepatitis C (HCV)
Schiffer, Celia A.   +2 more
core   +1 more source

Thrombin cleavage of the hepatitis E virus polyprotein at multiple conserved locations is required for genome replication.

open access: yesPLoS Pathogens, 2023
The genomes of positive-sense RNA viruses encode polyproteins that are essential for mediating viral replication. These viral polyproteins must undergo proteolysis (also termed polyprotein processing) to generate functional protein units.
Danielle M Pierce   +10 more
doaj   +1 more source

Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza

open access: yesFrontiers in Molecular Biosciences, 2021
The ongoing pandemic illustrates limited therapeutic options for controlling SARS-CoV-2 infections, calling a need for additional therapeutic targets. The viral spike S glycoprotein binds to the human receptor angiotensin-converting enzyme 2 (ACE2) and ...
Yalda Rahbar Saadat   +3 more
doaj   +1 more source

SPINK6 inhibits human airway serine proteases and restricts influenza virus activation

open access: yesEMBO Molecular Medicine, 2021
SPINK6 was identified in human skin as a cellular inhibitor of serine proteases of the KLK family. Airway serine proteases are required to cleave hemagglutinin (HA) of influenza A viruses (IAVs) to initiate an infection in the human airway.
Dong Wang   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy